Celsius Holdings, Inc. Common Stock
CELH
$29.33
-2.75%
Celsius Holdings operates in the energy drink subsegment of the global non-alcoholic beverage market, owning and marketing the Celsius, Alani Nu, and Rockstar Energy brands. The company has established itself as a high-growth disruptor in the category, leveraging a strategic distribution partnership with PepsiCo to expand its retail footprint rapidly. The current investor narrative is dominated by the company's transition into a multi-brand platform following the Alani Nu acquisition, which is seen as a key driver for sustaining growth, though this is juxtaposed against intense competition, valuation concerns, and recent significant stock price volatility.…
CELH
Celsius Holdings, Inc. Common Stock
$29.33
Related headlines
Investment Opinion: Should I buy CELH Today?
Rating & Thesis: Hold. CELH presents a high-risk, high-reward proposition where compelling growth potential is counterbalanced by severe execution risk and negative momentum, making it unsuitable for new investment until the growth trajectory clarifies. The limited analyst coverage (5 firms) with a wide revenue estimate range ($4.35B to $4.75B) underscores the high uncertainty.
Supporting Evidence: The recommendation is supported by four key data points: 1) The reasonable forward P/E of 14.78x is attractive for a growth story but is entirely dependent on hitting the $2.61 EPS estimate. 2) TTM Free Cash Flow of $323M demonstrates underlying business strength. 3) The stock is deeply oversold, trading just 9.5% above its 52-week low. 4) However, the severe sequential revenue stall (flat QoQ) and 32.5% three-month price decline indicate fundamental and technical deterioration that cannot be ignored.
Risks & Conditions: The two biggest risks are confirmation of growth deceleration in the next quarter and further earnings volatility leading to an EPS miss. This Hold would upgrade to a Buy if the company reports resumption of sequential revenue growth in the next quarter and demonstrates more consistent profitability, suggesting the integration is on track. It would downgrade to a Sell if revenue declines sequentially or if the forward P/E expands above 20x without a corresponding improvement in growth visibility. Currently, the stock is fairly valued relative to its heightened risk profile, but remains overvalued if the growth narrative has permanently shifted.
Sign up to view all
CELH 12-Month Price Forecast
The outlook for CELH is bifurcated and highly dependent on the next 1-2 quarters of execution. The base case (50% probability) is a period of consolidation, where the stock digests its massive de-rating and proves it can grow at a moderated but respectable pace. The bear case risk is elevated (25%) given the clear growth scare and high short interest. The bull case (25%) requires flawless execution to regain investor trust. The stance is neutral due to the high uncertainty; the data suggests waiting for confirmation that the growth engine is re-igniting before taking a bullish position. This stance would upgrade to bullish on a clear resumption of sequential revenue growth and downgrade to bearish on a confirmed sequential decline.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Celsius Holdings, Inc. Common Stock's 12-month outlook, with a consensus price target around $38.13 and implied upside of +30.0% versus the current price.
Average Target
$38.13
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$23 - $38
Analyst target range
Analyst coverage is limited with only 5 analysts providing estimates, indicating this is still considered a mid-cap growth story with evolving institutional interest. The consensus sentiment leans bullish, as evidenced by recent institutional ratings from firms like Deutsche Bank (upgraded to Buy) and sustained Overweight/Buy ratings from JP Morgan and Piper Sandler, though a notable Underperform from B of A Securities highlights the ongoing debate. The target price range is implied through revenue and EPS estimates rather than explicit price targets; the average revenue estimate for the forward period is $4.56 billion, with a wide range from $4.35 billion to $4.75 billion, reflecting high uncertainty about the company's near-term growth trajectory and the successful execution of its multi-brand strategy.
Bulls vs Bears: CELH Investment Factors
The bull and bear cases for CELH are in sharp conflict, centered on the interpretation of its explosive but potentially plateauing growth. Bulls see a cash-generative disruptor, now deeply oversold, trading at a reasonable forward multiple if it can execute on its multi-brand strategy. Bears see a growth story hitting a wall, with volatile earnings and a valuation that, while de-rated, still requires perfection. The bear side currently holds stronger evidence, given the clear sequential revenue stall, severe technical breakdown, and high short interest (ratio of 3.48). The single most important tension is whether the Q4 revenue plateau is a temporary integration hiccup or the first sign of a saturated growth narrative. The resolution of this question over the next two quarters will definitively shape the investment thesis.
Bullish
- Explosive Revenue Growth: Q4 2025 revenue grew 117.23% year-over-year to $721.63 million, demonstrating the company's powerful top-line expansion. This growth is fueled by the strategic PepsiCo distribution partnership and the successful acquisition of the Alani Nu brand, transforming Celsius into a multi-brand platform.
- Strong Cash Generation: The company generates robust free cash flow, with TTM FCF of $323.38 million. This provides significant financial flexibility to fund growth, service debt, and navigate the volatile quarterly earnings typical of a high-growth company integrating acquisitions.
- Attractive Forward Valuation: The forward P/E ratio of 14.78x is reasonable for a company with its growth profile, especially when compared to the trailing P/E of 99.61x. This suggests the market has already de-rated the stock significantly, potentially pricing in a more normalized, yet still strong, growth trajectory.
- Healthy Balance Sheet: A low debt-to-equity ratio of 0.23 and a solid current ratio of 1.68 indicate a conservative capital structure and ample liquidity. This financial strength reduces near-term solvency risk and provides a buffer against operational volatility.
Bearish
- Severe Growth Deceleration: Despite 117% YoY growth, Q4 2025 revenue of $721.63M was essentially flat sequentially from Q3's $725.11M. This plateau raises serious concerns about near-term saturation, integration challenges post-Alani Nu acquisition, or intensifying competition halting momentum.
- Extreme Earnings Volatility: Profitability is highly erratic, swinging from a net loss of -$61.01M in Q3 2025 to net income of $24.74M in Q4. This volatility, with a net margin of just 3.4% in the latest quarter, makes forecasting difficult and calls into question the sustainability of earnings.
- Massive Valuation De-Rating: The stock's Price-to-Sales ratio has collapsed from a historical 14.91x to just 4.28x, reflecting a severe loss of investor confidence. The trailing P/E of 99.6x remains exorbitant, indicating the market still demands flawless execution to justify any premium.
- Persistent Negative Momentum: The stock has significantly underperformed the market, down 14.51% over the past month versus the S&P 500's 5.6% gain, resulting in a -20.11 relative strength. This consistent negative momentum suggests selling pressure is ongoing, with no technical reversal in sight.
CELH Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -22.77% and a 3-month decline of -32.50%. Currently trading at $30.16, the price sits just 9.5% above its 52-week low of $27.66, positioning it near the bottom of its annual range, which suggests the stock is deeply oversold and may present a value opportunity, though it also risks being a 'falling knife' if negative momentum persists. Recent short-term momentum shows no signs of reversal, with the stock down 14.51% over the past month, a decline that has significantly underperformed the S&P 500's 5.6% gain, as indicated by a relative strength of -20.11, confirming severe weakness. Key technical levels are clear, with immediate support at the 52-week low of $27.66 and major resistance at the 52-week high of $66.74; a decisive break below support could trigger another leg down, while a recovery above $40 would be needed to signal a potential trend change. The stock's beta of 0.511 indicates it has been about 49% less volatile than the broader market over the measured period, which is unusual for a growth name and may reflect its recent de-rating and consolidation phase.
Beta
0.51
0.51x market volatility
Max Drawdown
-57.0%
Largest decline past year
52-Week Range
$28-$67
Price range past year
Annual Return
-25.5%
Cumulative gain past year
| Period | CELH Return | S&P 500 |
|---|---|---|
| 1m | -16.8% | +4.0% |
| 3m | -33.2% | +8.2% |
| 6m | -28.8% | +11.5% |
| 1y | -25.5% | +24.3% |
| ytd | -38.6% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CELH Fundamental Analysis
Revenue growth has been explosive but shows signs of sequential deceleration; the most recent quarterly revenue for Q4 2025 was $721.63 million, representing a massive 117.23% year-over-year increase, yet this follows a quarter (Q3 2025) where revenue was essentially flat sequentially at $725.11 million, indicating potential near-term saturation or integration challenges post-acquisition. Profitability is highly volatile on a quarterly basis, with Q4 2025 net income at $24.74 million (net margin of 3.4%) and gross margin at 47.37%, but this followed a significant loss of -$61.01 million in Q3 2025; the trailing twelve-month free cash flow is a robust $323.38 million, suggesting the business model can generate cash at scale despite quarterly income swings. The balance sheet appears healthy with a conservative debt-to-equity ratio of 0.23 and a strong current ratio of 1.68, providing ample liquidity; the substantial free cash flow generation supports the company's ability to fund growth internally and service its modest debt load, mitigating near-term financial risk.
Quarterly Revenue
$721628000.0B
2025-12
Revenue YoY Growth
+1.17%
YoY Comparison
Gross Margin
+0.47%
Latest Quarter
Free Cash Flow
$323375000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CELH Overvalued?
Given the company's positive net income in the most recent quarter, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE is extremely elevated at 99.61x, while the forward PE is a much more reasonable 14.78x; this massive gap implies the market is pricing in a dramatic acceleration in earnings growth over the next twelve months, heavily reliant on the successful integration of recent acquisitions and margin expansion. Compared to the broader Consumer Defensive sector, the stock's Price-to-Sales (PS) ratio of 4.28x is not provided with a direct industry average, but the trailing PE of 99.6x is undoubtedly at a significant premium to most mature beverage companies, a premium that must be justified by its superior growth profile and market share gains. Historically, the stock's own valuation has compressed sharply; its current PS ratio of 4.28x is far below its historical PS of 14.91x from Q4 2025, indicating the market has significantly de-rated the stock due to growth concerns, moving it from pricing perfection to potentially pricing in a more normalized growth trajectory.
PE
99.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -179x~1784x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
54.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: CELH's primary financial risk is extreme earnings volatility, as evidenced by the swing from a -$61M loss in Q3 2025 to a $24.7M profit in Q4. This makes the forward P/E of 14.78x highly sensitive to any quarterly miss. Furthermore, while revenue grew 117% YoY, the sequential flatness from Q3 to Q4 ($725M to $722M) signals potential growth deceleration risk. The company's valuation remains heavily reliant on sustaining high growth rates to justify even its de-rated multiples, creating a binary outcome dependent on flawless execution of its multi-brand strategy.
Market & Competitive Risks: The stock faces severe valuation compression risk, having already seen its PS ratio fall from 14.91x to 4.28x. If growth continues to decelerate, further multiple contraction is likely. Intense competition, specifically noted from giants like Costco, threatens market share and pricing power in the crowded energy drink sector. The stock's low beta of 0.511 is deceptive; it reflects recent de-rating and consolidation, not low volatility, as shown by the -57.05% max drawdown. Recent news highlights the ongoing debate, with analysts split between upgrades (Deutsche Bank) and underperform ratings (B of A Securities).
Worst-Case Scenario: The worst-case scenario involves the Q4 revenue plateau confirming a permanent growth slowdown, triggering a loss of confidence in the multi-brand strategy. This could lead to missed analyst EPS estimates, a wave of downgrades, and a re-rating towards a more traditional beverage company multiple. Coupled with intensified competition squeezing margins, the stock could retest and break below its 52-week low of $27.66. A realistic downside from the current $30.16 could be -30% to -40%, targeting a range of $18-$21, reflecting a scenario where growth normalizes sharply and the forward P/E compresses to single digits.
FAQ
The key risks are, in order of severity: 1) Growth Deceleration: The most pressing risk is that the flat sequential revenue in Q4 2025 becomes a trend, invalidating the high-growth narrative. 2) Earnings Volatility: Profitability swings wildly (from -$61M to +$25M in consecutive quarters), making the forward P/E target unreliable. 3) Competitive & Market Risk: Intense competition from large players like Costco could pressure margins and market share. 4) Valuation Compression: The stock has already de-rated sharply, but further multiple contraction is possible if growth slows more than expected.
The 12-month forecast is highly uncertain, with three distinct scenarios. The base case (50% probability) sees the stock trading between $35 and $45 as growth moderates but the company meets analyst estimates. The bull case (25% probability) targets $55 to $66 if growth re-accelerates and confidence returns. The bear case (25% probability) warns of a drop to $20-$28 if the growth stall confirms a permanent slowdown. The most likely outcome is the base case, but the wide range reflects the critical assumption that the company can stabilize its growth rate above zero on a sequential basis.
CELH's valuation is in a state of flux and is best described as fairly valued given the current high risk. The trailing P/E of 99.6x is stratospheric and clearly overvalued. However, the forward P/E of 14.78x suggests the market has already priced in significant de-rating. This forward multiple is reasonable if the company hits its $2.61 EPS target, but it implies the market expects strong earnings growth from a low base. Compared to its own history, the stock is cheap (PS of 4.28x vs. historical 14.91x), but this discount reflects justified concerns about slowing growth.
CELH is not a good buy for most investors at this moment due to high uncertainty. While the forward P/E of 14.78x appears reasonable and the stock is deeply oversold, the investment thesis is clouded by a severe sequential revenue stall and extreme earnings volatility. It could be a good buy for very risk-tolerant investors who believe the growth narrative will re-ignite, but they must be prepared for significant downside, potentially another 30-40% if the bear case plays out. A more prudent approach is to wait for the next quarterly report to confirm whether growth has resumed.
CELH is unsuitable for short-term trading due to its high volatility and current negative momentum; it is a 'falling knife.' For long-term investment, it carries high speculative risk, as the long-term thesis depends on successfully proving its multi-brand strategy over several quarters. The minimum suggested holding period for a long-term investor is 2-3 years, to see through the current integration phase and potential re-acceleration. However, given the uncertainty, it is more appropriate for an active, watchlist-driven investment style where positions are sized small and adjusted based on quarterly execution, rather than a traditional buy-and-hold approach.
